HNW
IDXX icon

High Note Wealth’s Idexx Laboratories IDXX Stock Holding History

High Note Wealth’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.79K Sell
11
-1
-8% -$561 ﹤0.01% 543
2026
Q1 		$6.74K Buy
12
+3
+33% +$1.92K ﹤0.01% 446
2025
Q4 		$6.09K Buy
9
+2
+29% +$1.36K ﹤0.01% 438
2025
Q3 		$4.47K Hold
7
– – ﹤0.01% 520
2025
Q2 		$3.75K Buy
7
+3
+75% +$1.44K ﹤0.01% 555
2025
Q1 		$1.68K Buy
+4
New +$1.74K ﹤0.01% 700

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

High Note Wealth's IDXX Position: Q2 2026 in Review

High Note Wealth reduced its Idexx Laboratories (IDXX) stake by 8.3% in Q2 2026, selling an estimated $561 and leaving 11 shares worth $5.79K. The position accounts for ﹤0.01% of the portfolio, ranked #543.

High Note Wealth first reported a position in IDXX in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.74K in Q1 2026. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • High Note Wealth held 11 shares of Idexx Laboratories worth $5.79K as of Q2 2026.
  • High Note Wealth sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
  • Idexx Laboratories made up ﹤0.01% of High Note Wealth's portfolio in Q2 2026, its #543 holding.
  • High Note Wealth first reported a position in Idexx Laboratories in Q1 2025 and has held it in 6 quarters since.
  • High Note Wealth's Idexx Laboratories position peaked at $6.74K in Q1 2026.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on High Note Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.